104 related articles for article (PubMed ID: 3678326)
1. Increased uptake of 5-FU in experimental liver tumours by simultaneous infusion of norepinephrine.
Vagianos C; Puntis M; Jeppsson B; Steen S; Zoucas E; Bengmark S
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1323-7. PubMed ID: 3678326
[TBL] [Abstract][Full Text] [Related]
2. Effect of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model.
Dworkin MJ; Zweit J; Carnochan P; Deehan B; Allen-Mersh TG
Eur J Cancer; 1996 Aug; 32A(9):1580-4. PubMed ID: 8911121
[TBL] [Abstract][Full Text] [Related]
3. Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.
Shankar A; Loizidou M; Burnstock G; Taylor I
Br J Surg; 1999 Apr; 86(4):453-7. PubMed ID: 10215813
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
Engelbrecht C; Ljungquist I; Lewan L; Yngner T
Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
Roos G; Stenram U
J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
[TBL] [Abstract][Full Text] [Related]
7. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
el Hag IA; Jakobsson B; Jönsson PE; Stenram U
Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018
[TBL] [Abstract][Full Text] [Related]
8. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
Brix G; Bellemann ME; Haberkorn U
Magn Reson Med; 1999 Nov; 42(5):936-43. PubMed ID: 10542353
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor infusion increases tumour vascularity, blood flow and chemotherapy uptake.
Davies MM; Burke D; Carnochan P; Glover C; Kaur S; Allen-Mersh TG
Acta Oncol; 2002; 41(1):84-90. PubMed ID: 11990524
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
11. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
12. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
[TBL] [Abstract][Full Text] [Related]
14. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
15. The influence of degradable starch microspheres on liver uptake of 5-fluorouracil after hepatic artery injection in the rat.
Teder H; Aronsen KF; Björkman S; Lindell B; Ljungberg J
J Pharm Pharmacol; 1986 Dec; 38(12):939-41. PubMed ID: 2880975
[TBL] [Abstract][Full Text] [Related]
16. In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue.
de Brauw LM; van de Velde CJ; Tjaden UR; de Bruijn EA; Bell AV; Hermans J; Zwaveling A
J Surg Res; 1988 Feb; 44(2):137-45. PubMed ID: 3339874
[TBL] [Abstract][Full Text] [Related]
17. Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging.
Brix G; Bellemann ME; Gerlach L; Haberkorn U
Magn Reson Imaging; 1999 Jan; 17(1):151-5. PubMed ID: 9888408
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing rats.
Pohlen U; Reszka R; Buhr HJ; Berger G
Anticancer Res; 2011 Jan; 31(1):147-52. PubMed ID: 21273592
[TBL] [Abstract][Full Text] [Related]
19. Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
Yoshisue K; Kanie S; Nishimura T; Chikamoto J; Nagayama S
J Pharm Pharmacol; 2009 Dec; 61(12):1643-51. PubMed ID: 19958587
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy.
McSheehy PM; Seymour MT; Ojugo AS; Rodrigues LM; Leach MO; Judson IR; Griffiths JR
Eur J Cancer; 1997 Dec; 33(14):2418-27. PubMed ID: 9616292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
